ADJUVANT HIGH-DOSE EPIRUBICIN AND CYCLOPHOSPHAMIDE WITH G-CSF SUPPORT IN PATIENTS WITH LOCALLY ADVANCED BREAST-CANCER

被引：0
|
作者：
KONECNY, G [1 ]
UNTCH, M [1 ]
BAUERFEIND, I [1 ]
PICHE, E [1 ]
NESTLEKRAMLING, C [1 ]
机构：
[1] UNIV MUNICH,KLINIKUM GROSSHADERN,FRAUENHEILKUNDE & GEBURTSHILFE KLIN & POLIKLIN,MUNICH,GERMANY
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant moderately high-dose chemotherapy with rh-G-CSF in locally advanced breast carcinoma
    Fornasiero, A
    Ghiotto, C
    Daniele, O
    Favaretto, AG
    D'Amanzo, P
    Ziade, A
    TUMORI JOURNAL, 2001, 87 (04): : 223 - 228
  • [42] Phase II trial of neoadjuvant docetaxel and carboplatin with filgrastim (G-CSF) support in patients with locally advanced breast cancer.
    Karmarkar, S
    Jones, D
    Hatch, S
    Klementich, F
    Ansari, K
    Grube, B
    Chao, C
    Townsend, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 74S - 74S
  • [43] Neo-adjuvant chemotherapy with GM- or G-CSF: Differential effects on DC subsets in patients with locally advanced breast cancer
    Stam, Anita
    van Cruijsen, Hester
    Pohlmann, Paula
    Luijkx-de Bakker, Sylvia
    van der Wall, Elsken
    Buter, Jan
    van den Eertwegh, Fons
    Hoekman, Klaas
    Scheper, Rik
    Pinedo, Bob
    de Gruijl, Tanja
    CANCER RESEARCH, 2009, 69
  • [44] Adjuvant high-dose chemotherapy with epirubicin and ifosfamide in nodal positive breast cancer
    Lüftner, D
    Wagner, K
    Dingeldein, G
    Haas, A
    Sezer, O
    Mergenthaler, HG
    Wernecke, KD
    Possinger, K
    ANTICANCER RESEARCH, 1999, 19 (4C) : 3583 - 3590
  • [45] Docetaxel and epirubicin plus G-CSF for mobilization of peripheral blood progenitor cells to support high dose chemotherapy in poor prognosis breast cancer
    Perillo, A
    De Rosa, L
    Lalle, M
    Pierelli, L
    Salerno, MG
    Cortesi, E
    Martelli, O
    Pandolfi, A
    Amodeo, R
    Marzetti, L
    Mancuso, S
    Scambia, G
    BONE MARROW TRANSPLANTATION, 2001, 27 : S120 - S121
  • [46] Comparison between mobilization with G-CSF versus G-CSF plus cyclophosphamide based chemotherapy in patients with breast cancer
    Arbona, C
    Mena, F
    Prosper, F
    Benet, I
    Lluch, A
    Garcia-Conde, J
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 780 - 780
  • [47] A PILOT-STUDY OF INTENSIVE CYCLOPHOSPHAMIDE, EPIRUBICIN AND FLUOROURACIL IN PATIENTS WITH AXILLARY NODE POSITIVE OR LOCALLY ADVANCED BREAST-CANCER
    LEVINE, MN
    BRAMWELL, V
    PRITCHARD, K
    PERRAULT, D
    FINDLAY, B
    ABUZAHRA, H
    WARR, D
    ARNOLD, A
    SKILLINGS, J
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (01) : 37 - 43
  • [48] HIGH-DOSE EPIRUBICIN IN COMBINATION WITH CYCLOPHOSPHAMIDE (HD-EC) IN ADVANCED BREAST-CANCER - FINAL RESULTS OF A DOSE FINDING STUDY AND PHASE-II TRIAL
    MARSCHNER, N
    NAGEL, GA
    BEYER, JH
    ADLER, M
    AMMON, A
    ONKOLOGIE, 1990, 13 (04): : 272 - 278
  • [49] Docetaxel and cyclophosphamide as adjuvant chemotherapy for early breast cancer: primary prophylaxis with G-CSF is required
    Lakhanpal, Roopa
    Stuart-Harris, Robin
    Chan, Arlene
    Kotasek, Dusan
    Beith, Jane
    Cuff, Katharine
    Bastick, Patricia
    Lee, Clara
    BREAST CANCER MANAGEMENT, 2013, 2 (05) : 367 - 374
  • [50] A phase II study of high-dose epirubicin (EPI) plus cyclophosphamide (CPA) with G-CSF for breast cancer patients with visceral metastases or hormone-independent tumors: A trial of the Japan Clinical Oncology Group
    Takashima, S
    Saeki, T
    Adachi, I
    Watanabe, T
    Sasaki, Y
    Murai, H
    Tabei, T
    Ogita, M
    Sano, M
    Kanda, K
    Shimoyama, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (05) : 325 - 330
12345